Axcella Health Inc.: Nasdaq/NYSE listing notice — Axcella Health receives Nasdaq delisting notice for late Q3 10-Q filing

Axcella Health Inc.

Nasdaq notified Axcella on Nov 16, 2023 of non-compliance with Listing Rule 5250(c)(1) due to failure to file Q3 2023 Form 10-Q.
The Nasdaq Hearings Panel will consider the matter and decide on continued listing on The Nasdaq Global Market.
If delisted, AXLA shares could be subject to removal from Nasdaq, affecting liquidity and trading.
Company faces risk of losing Nasdaq listing unless it regains compliance with SEC filing requirements.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Axcella Health Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

November 16, 2023, Axcella Health Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with the continued listing requirements of Nasdaq Listing Rule 5250(c)(1) because its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 had not yet been filed with the Securities and Exchange Commission (“SEC”). The Nasdaq Hearings Panel (the “Panel”) will consider this matter in its decision regarding the Company’s continued listing on The Nasdaq Global Market. Forward Lo

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-119563

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.